Pfizer and Valenva are seeking regulatory approval from the Food and Drug Administration for a Lyme disease vaccine in development that's more than 70% effective against the tick-borne illness.
An exclusive interview with Pfizer’s Wayne Simmons on reshaping customer experience by listening to those interacting with healthcare professionals. LAS VEGAS — Even in a $63.6 billion, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results